Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (2,465) Arrow Down
Filter Results: (2,465) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (5,158)
    • People  (16)
    • News  (1,906)
    • Research  (2,465)
    • Events  (2)
    • Multimedia  (221)
  • Faculty Publications  (1,885)

Show Results For

  • All HBS Web  (5,158)
    • People  (16)
    • News  (1,906)
    • Research  (2,465)
    • Events  (2)
    • Multimedia  (221)
  • Faculty Publications  (1,885)
← Page 112 of 2,465 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • Article

Use of Crowd Innovation to Develop an Artificial Intelligence-Based Solution for Radiation Therapy Targeting

By: Raymond H. Mak, Michael G. Endres, Jin Hyun Paik, Rinat A. Sergeev, Hugo Aerts, Christopher L. Williams, Karim R. Lakhani and Eva C. Guinan
Importance: Radiation therapy (RT) is a critical cancer treatment, but the existing radiation oncologist work force does not meet growing global demand. One key physician task in RT planning involves tumor segmentation for targeting, which requires substantial... View Details
Keywords: Crowdsourcing; AI Algorithms; Health Care and Treatment; Collaborative Innovation and Invention; AI and Machine Learning
Citation
Find at Harvard
Read Now
Related
Mak, Raymond H., Michael G. Endres, Jin Hyun Paik, Rinat A. Sergeev, Hugo Aerts, Christopher L. Williams, Karim R. Lakhani, and Eva C. Guinan. "Use of Crowd Innovation to Develop an Artificial Intelligence-Based Solution for Radiation Therapy Targeting." JAMA Oncology 5, no. 5 (May 2019): 654–661.
  • August 2003 (Revised August 2006)
  • Case

I've Got Rhythm: Selling Cardiac Rhythm Management Devices

By: Regina E. Herzlinger, William Lagor, Christopher Perry and Scott St. Germain
The head of sales and marketing in a large medical devices firm must decide how to assign his sales force. He compares selling in the pharma, specialty pharma, and device industries and analyzes the reasons for the differences. View Details
Keywords: Health Care and Treatment; Marketing Strategy; Industry Structures; Sales; Salesforce Management; Medical Devices and Supplies Industry
Citation
Educators
Purchase
Related
Herzlinger, Regina E., William Lagor, Christopher Perry, and Scott St. Germain. "I've Got Rhythm: Selling Cardiac Rhythm Management Devices." Harvard Business School Case 304-012, August 2003. (Revised August 2006.)
  • October 1992 (Revised September 1993)
  • Case

Nopane Advertising Strategy

By: David E. Bell
Nopane is a proprietary drug that sells in much of the United States. It faces substantial competition. The brand manager is undertaking an experiment to determine whether ad copy should be emotional-based or rational-based. The data and associated regression results... View Details
Keywords: Competition; Intellectual Property; Advertising; Health Care and Treatment; Brands and Branding; Product Marketing; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
Bell, David E. "Nopane Advertising Strategy." Harvard Business School Case 893-005, October 1992. (Revised September 1993.)
  • January 2023
  • Case

The END Fund: To Eliminate Neglected Tropical Diseases

By: V. Kasturi Rangan and Courtney Han
Founded in 2012, the END fund focused on eliminating five Neglected Tropical Diseases that accounted for 80% of the tropical diseases affecting nearly 1.5 billion people worldwide. Its roughly $25 million/year annual budget was fully committed when it got news that the... View Details
Keywords: Nonprofit Organizations; Health Disorders; Health Care and Treatment; Resource Allocation; Global Range; Decisions; Investment Funds
Citation
Educators
Purchase
Related
Rangan, V. Kasturi, and Courtney Han. "The END Fund: To Eliminate Neglected Tropical Diseases." Harvard Business School Case 523-063, January 2023.
  • 16 May 2016
  • HBS Case

Food Safety Economics: The Cost of a Sick Customer

Business School and Professor in Health Policy and Management at the Harvard T.H. Chan School of Public Health. Even though Chipotle’s supply chain is shorter, with fewer intermediaries between supplier and restaurant, the use of local... View Details
Keywords: by Dina Gerdeman; Food & Beverage
  • 13 May 2008
  • First Look

First Look: May 13, 2008

community-based health center) are also discussed. Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=308072 Global Climate Change and BP Harvard Business School Case 708-026 Following the sudden... View Details
Keywords: Martha Lagace
  • 22 Nov 2016
  • First Look

November 22, 2016

regulated entities’ compliance with law. The integrity of these regulatory regimes rests on the validity of the information third-party monitors provide to regulators. The challenge in designing third-party monitoring regimes is that... View Details
Keywords: Sean Silverthorne
  • 23 Jan 2012
  • Research & Ideas

Break Your Addiction to Service Heroes

that there are a lot of heroic people in service organizations who feel compelled to be the best at everything. That's particularly evident in mission-driven and health care organizations, where managers... View Details
Keywords: by Deborah Blagg; Service
  • 28 Apr 2010
  • Research & Ideas

Earth Day Reflections

opportunity to engage in a virtual dialogue on these matters. Some major corporations are starting to take the lead in this effort, including United Technologies Corporation, Philips (the Dutch electronics and health View Details
Keywords: by Staff
  • February 2024
  • Teaching Note

Compass Pathways: Pioneering Psychedelic Treatment

By: Tiona Zuzul
Teaching Note for HBS Case No. 724-412. View Details
Keywords: Commercialization; Corporate Strategy; Competitive Strategy; Product Launch; Health Care and Treatment; Pharmaceutical Industry; Europe; United States; United Kingdom
Citation
Purchase
Related
Zuzul, Tiona. "Compass Pathways: Pioneering Psychedelic Treatment." Harvard Business School Teaching Note 724-457, February 2024.
  • March 2016
  • Case

Residency Select or J3Personica?

By: William Kerr and Kathryn S. Roloff
Residency Select, LLC provides psychometric assessments for matching medical students to residency programs. After a series of successful pilots, founder Alan Friedman is considering whether to continue developing his offerings in this area, or whether to expand into... View Details
Keywords: Marketplace Matching; Expansion; Higher Education; Entrepreneurship; Health Care and Treatment; Growth and Development Strategy; Service Industry
Citation
Educators
Purchase
Related
Kerr, William, and Kathryn S. Roloff. "Residency Select or J3Personica?" Harvard Business School Case 816-088, March 2016.
  • 19 Feb 2013
  • First Look

First Look: Feb. 19

  PublicationsLabor Regulations and European Venture Capital Authors:Bozkaya, Ant, and William R. Kerr Publication:Journal of Economics & Management Strategy Abstract European nations substitute between employment protection View Details
Keywords: Sean Silverthorne
  • 03 Mar 2008
  • First Look

First Look: March 4, 2008

company. A simple portfolio strategy of going long the buy recommendations with school ties and going short buy recommendations without ties earns returns of 5.40% per year. We test whether Regulation FD, targeted at impeding selective... View Details
Keywords: Martha Lagace
  • 20 Nov 2012
  • First Look

First Look: November 20

their increased tendency to behave fairly. Read the paper: http://www.people.hbs.edu/mnorton/shaw et al.pdf Robust Enforcement Should Complement Voluntary Regulation Authors:Jodi L. Short and Michael W. Toffel Publication:Georgetown... View Details
Keywords: Sean Silverthorne
  • 06 Jan 2012
  • Op-Ed

Where Green Corporate Ratings Fail

illustration of this omission, Apple, a US consumer electronics manufacturer, publicly resigned in 2009 from the US Chamber of Commerce, the largest business lobbying group in the country. "Apple supports regulating greenhouse gas... View Details
Keywords: by Michael Toffel & Auden Schendler; Information; Publishing
  • 09 Oct 2012
  • First Look

First Look: October 9

this time. Read the article: http://hbr.org/2012/10/great-leaders-dont-need-experience/ar/1   Working PapersTeam Scaffolds: How Minimal In-Group Structures Support Fast-Paced Teaming Authors:Melissa Valentine and Amy C. Edmondson Abstract Across many industries,... View Details
Keywords: Sean Silverthorne
  • October 2009 (Revised August 2014)
  • Case

Tengion: Bringing Regenerative Medicine to Life

By: Elie Ofek and Polly Ross Ribatt
Tengion is a young biotech company that is at the frontier of regenerative medicine—a nascent field that seeks to promote the creation of new cells and tissue to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. In late... View Details
Keywords: Decision Choices and Conditions; Financial Crisis; Entrepreneurship; Health Care and Treatment; Technological Innovation; Product Launch; Product Development; Research and Development; Biotechnology Industry; United States
Citation
Educators
Purchase
Related
Ofek, Elie, and Polly Ross Ribatt. "Tengion: Bringing Regenerative Medicine to Life." Harvard Business School Case 510-031, October 2009. (Revised August 2014.)
  • 18 Feb 2015
  • First Look

First Look: February 18

https://cb.hbsp.harvard.edu/cbmp/product/715411-PDF-ENG Harvard Business School Case 715-423 Discovery Limited Discovery Limited is a South-African based insurance company. Started in the early 1990s, Discovery used behavioral economics and data collection to innovate... View Details
Keywords: Sean Silverthorne
  • 2024
  • Working Paper

Ultrasound Imaging--Cheap, Versatile, and Safe: Case Histories of Transformational Advances

By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how efforts on multiple fronts, including advocacy, training, and technological development, made ultrasound the second most commonly used diagnostic imaging technology (after X-rays). Specifically, we chronicle 1) ultrasound’s development... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Citation
SSRN
Read Now
Related
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Ultrasound Imaging--Cheap, Versatile, and Safe: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-003, July 2019. (Revised May 2024.)
  • 05 Aug 2015
  • What Do You Think?

What Happened to the ‘Innovation, Disruption, Technology’ Dividend?

W. Norton & Company, 2014). Martin Ford, Rise of the Robots: Technology and the Threat of a Jobless Future (New York: Basic Books, 2015). James L. Heskett, W. Earl Sasser, Jr., and Leonard A. Schlesinger, What Great Service Leaders Know and Do: Creating... View Details
Keywords: by James Heskett; Computer; Technology
  • ←
  • 112
  • 113
  • …
  • 123
  • 124
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.